Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study
OBJECTIVEWe characterized the impact of the metabolic syndrome (MetS) and its components on cardiovascular adverse events in patients with symptomatic chronic multivessel coronary artery disease, which have been followed prospectively for 2 years. METHODSPatients enrolled in the MASS II study were e...
Gespeichert in:
Veröffentlicht in: | Coronary artery disease 2008-09, Vol.19 (6), p.383-388 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVEWe characterized the impact of the metabolic syndrome (MetS) and its components on cardiovascular adverse events in patients with symptomatic chronic multivessel coronary artery disease, which have been followed prospectively for 2 years.
METHODSPatients enrolled in the MASS II study were evaluated for each component of the MetS, as well as the full syndrome.
RESULTSThe criteria for MetS were fulfilled in 52% of patients. The presence of MetS (P |
---|---|
ISSN: | 0954-6928 1473-5830 |
DOI: | 10.1097/MCA.0b013e328306aa8a |